Please login to the form below

Not currently logged in
Email:
Password:

Genocea Biosciences

This page shows the latest Genocea Biosciences news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II

Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus. ... The vaccine - called GEN-003 and developed by Genocea Biosciences - is a T cell-enabled therapeutic vaccine designed to reduce the duration and severity of

Latest news

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    outbreaks. Last year, Sanofi set up an alliance with Immune Design to develop a therapeutic vaccine for HSV-2 based on their two vaccine candidates, while Genocea Biosciences, Agenus and Tomegavax

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics